Sentilus' Acquisition

Sentilus was acquired by Immucor on October 01, 2014.

Sentilus is a privately-held company focused on developing a novel, inkjet-printed antibody microarray-based technology, Femtoarrays. Sentilus has been developing Femtoarrays and the underlying techno…

Articles about Sentilus' Acquisition: